U.S. Entertainment Stock News

Anterix (ATEX) has drawn attention after recent trading, with the stock last closing at $63.57 and showing strong short term and past 3 months moves. This has prompted investors to reassess its current pricing. See our latest analysis for Anterix. Recent momentum has been strong, with a 30 day share price return of 40.73% and a year to date share price return of 185.96%. The 1 year total shareholder return of 134.58% points to sustained interest over a longer period. If this kind of move has...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Expedia...

It looks like Copa Holdings, S.A. ( NYSE:CPA ) is about to go ex-dividend in the next 4 days. Typically, the...

Restaurant Brands International recently reported earnings that exceeded expectations, supported by steadier US Burger King same-store sales, and later held a fireside chat with its executive chairman and CEO at Bernstein’s 42nd Annual Strategic Decisions Conference, with the discussion streamed via its investor relations website. The combination of earnings outperformance and attention from high-profile investor Seth Klarman, who holds the company as his largest position, has sharpened...

Earlier in May 2026, BeOne Medicines received U.S. FDA accelerated approval for BEQALZI (sonrotoclax), a next-generation BCL2 inhibitor for adults with relapsed or refractory mantle cell lymphoma after at least two prior systemic therapies including a BTK inhibitor. This first U.S. approval for sonrotoclax reshapes BeOne’s oncology profile by adding a new commercial pillar alongside its BTK franchise and broad late-stage pipeline. We’ll now examine how adding BEQALZI as an approved BCL2...

Enovis (ENOV) has drawn attention after filing a US$92.16 million shelf registration to potentially issue up to 3,650,000 common shares in an employee stock ownership plan related offering. See our latest analysis for Enovis. The shelf registration and recent insider stock grants come as the share price trades at US$24.19, with a 90 day share price return of 7.89% but a 1 year total shareholder return that declined 23.35%. This indicates some recent momentum after a longer period of weaker...

In May 2026, Deere & Company reported fiscal second-quarter results showing revenue rising to US$13.37 billion while net income eased slightly to US$1.77 billion, and reaffirmed full-year 2026 net income guidance of US$4.5 billion to US$5.0 billion. Beneath the headline beat on earnings per share, performance tilted away from large agricultural equipment toward faster-growing Construction & Forestry and Small Agriculture & Turf, highlighting how Deere’s profit mix is shifting as farm markets...

In May 2026, Oruka Therapeutics reported a first-quarter net loss of US$31.82 million and disclosed insider stock option exercises and share sales by Senior Vice President Arjun Agarwal under a pre-arranged Rule 10b5-1 trading plan. Ahead of this, the company announced encouraging interim Phase 2a results for its ORKA-001 plaque psoriasis candidate and priced an upsized public offering of about US$700.40 million to support its development programs. Next, we’ll examine how the positive...

Kaiser Aluminum has recently benefited from stronger analyst sentiment and an improved earnings outlook, supported by industry-wide strength in aluminum amid supply disruptions and tariffs earlier this year. An interesting angle is that this improved outlook comes alongside signs of rich valuation metrics and recent insider selling, creating a complex setup for investors assessing the company’s current position. With analyst earnings expectations rising, we’ll now examine how this brighter...

It looks like First National Corporation ( NASDAQ:FXNC ) is about to go ex-dividend in the next 4 days. Typically, the...

Recent performance snapshot for STAAR Surgical STAAR Surgical (STAA) has drawn attention after a strong share price move, with the stock up about 26% over the past month and about 78% over the past 3 months. See our latest analysis for STAAR Surgical. At the current share price of US$32.47, STAAR Surgical’s recent 30 day share price return of 26.5% and 90 day share price return of 78.4% contrast with a 5 year total shareholder return that is down 77.8%, suggesting momentum has picked up after...

In May 2026, Lumentum Holdings Inc. was added to the Nasdaq-100 Index, coinciding with record fiscal Q3 2026 results driven by demand for its optical and photonic products in AI data centers and cloud networking. At the same time, the launch of a 2X leveraged ETF tied to Lumentum and a multi-billion-dollar NVIDIA investment underscored the company’s growing role in AI infrastructure and investor efforts to gain amplified exposure to this theme. We’ll now examine how Lumentum’s Nasdaq-100...

Zebra Technologies (ZBRA) has drawn fresh attention after raising its full year and second quarter sales growth guidance, alongside first quarter revenue of US$1,495 million and net income of US$135 million. See our latest analysis for Zebra Technologies. The guidance upgrade and recent earnings have contributed to a rebound in the share price, with a 1 month share price return of 12.23% and a 90 day gain of 10.47%. However, the 1 year total shareholder return is still down 10.08%, indicating...

Proto Labs (PRLB) drew fresh attention after reporting first quarter revenue growth of 10.4% year on year, along with EPS guidance for the upcoming quarter that came in ahead of analyst expectations. See our latest analysis for Proto Labs. The stock has responded positively around the earnings release, with a 1-month share price return of 10.43% and a year to date share price return of 38.97%. The 1-year total shareholder return of 93.81% points to strong recent momentum compared with a...

Teekay (TK) has moved back onto investor radars after reporting first quarter 2026 sales of US$286.09 million and net income of US$153.55 million, alongside a US$1.00 per share special dividend announcement. See our latest analysis for Teekay. The recent special dividend and first quarter earnings update come after a period of strong momentum, with a year to date share price return of 51.25% and a 1 year total shareholder return of 82.14%, suggesting improving sentiment around Teekay’s...

AvalonBay Communities (AVB) stock has drawn fresh attention after a recent move that leaves it trading at about $185.65, with performance over the past month, past 3 months, and year giving investors more data to assess. See our latest analysis for AvalonBay Communities. The recent 7.7% 1 month share price return and 5.3% 3 month share price return suggest improving momentum, although the 1 year total shareholder return of a 2.6% decline shows the longer term picture is still mixed. If this...

In May 2026, Coupang reported quarterly revenue growth but moved to a net loss, with adjusted EBITDA shrinking, prompting a Citi downgrade and coinciding with the announcement of a US$391 million stock repurchase plus an additional US$1.00 billion buyback authorization. A separate announcement highlighted how Coupang’s global logistics network helped a small U.S. salt producer, J.Q. Dickinson Salt-Works, access customers in more than 190 countries and regions, showcasing the company’s role...

In May 2026, Dana Incorporated reported past first-quarter 2026 results showing sales of US$1,868 million versus US$1,781 million a year earlier, with net income rising to US$1.09 billion from US$25 million, while still recording a basic loss per share of US$0.17 from continuing operations. The contrast between the very large net income and the loss per share from continuing operations suggests that one-off or non-core items played a major role in shaping overall profitability. We’ll now...

Why Pebblebrook’s preferred shares are drawing attention Recent analysis of Pebblebrook Hotel Trust (PEB) has focused on its Series G preferred shares, which are trading below liquidation value while offering a strong yield, supported by asset coverage and fixed charge coverage ratios. See our latest analysis for Pebblebrook Hotel Trust. PEB’s recent preferred share focus sits alongside a solid rebound in the common stock, with the share price up 20.36% over 90 days and a 67.22% total...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like Evercore Inc. ( NYSE:EVR ) is about to go ex-dividend in the next 4 days. The ex-dividend date is usually...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like AngloGold Ashanti plc ( NYSE:AU ) is about to go ex-dividend in the next four days. The ex-dividend date...